Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-04
DOI
10.3389/fimmu.2021.598799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management
- (2020) Yan Li et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Hypertension and COVID-19
- (2020) Ernesto L Schiffrin et al. AMERICAN JOURNAL OF HYPERTENSION
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- A Dynamic Immune Response Shapes COVID-19 Progression
- (2020) Eugenia Ziying Ong et al. Cell Host & Microbe
- COVID‐19 and diabetes
- (2020) R. C. W. Ma et al. DIABETIC MEDICINE
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Detection of SARS-CoV-2 in Different Types of Clinical Specimens
- (2020) Wenling Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)
- (2020) Ying Zhu et al. JOURNAL OF INFECTION
- Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19
- (2020) Yafang Li et al. JOURNAL OF MEDICAL VIROLOGY
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- Acute kidney injury in patients hospitalized with COVID-19
- (2020) Jamie S. Hirsch et al. KIDNEY INTERNATIONAL
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
- (2020) Selman Kesici et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Management of acute kidney injury in patients with COVID-19
- (2020) Claudio Ronco et al. Lancet Respiratory Medicine
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Use of convalescent plasma in hospitalized patients with COVID-19: case series
- (2020) Livia Hegerova et al. BLOOD
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients
- (2020) Christina C. Price et al. CHEST
- Response to: ‘Correspondence on ‘Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study’ by Potere et al’ by Buckley
- (2020) Nicola Potere et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
- (2020) Yong Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started